You are here

Heart Failure


The FDA has expanded its premarket approval for Impella heart pumps to include treatment for heart failure associated with cardiomyopathy leading to cardiogenic shock, device manufacturer Abiomed announced Feb. 13.

Exposure to noise pollution has been shown to negatively impact cardiovascular health. But researchers have only recently begun to explore exactly how noise can harm health. A study published online Feb. 6 in the Journal of the American College of Cardiology explored the connection between noise and arterial hypertension, myocardial infarction, heart failure and stroke.

Aspirin is ineffective in preventing heart attack, stroke and death in heart failure patients without atrial fibrillation (AFib), according to a nationwide study in Denmark. In fact, patients on aspirin may be more likely to have myocardial infarction (MI) or be rehospitalized for heart failure, Christian Madelaire, MD, and colleagues reported in JACC: Heart Failure.

Certain breast cancer therapies, including popular HER-2 targeted treatments, could be harmful to the heart in patients already at an increased risk for cardiovascular disease (CVD), the American Heart Association reported this week in a new scientific statement.

Only 30 percent of Medicare patients who received ventricular assist devices (VADs) in 2014 attended cardiac rehabilitation, but those patients enjoyed significant decreases in hospitalizations and mortality over the following year, according to a study in JACC: Heart Failure.


Recent Headlines

HER2-targeted breast cancer treatments come with cardiovascular risks

Cardiotoxicity has been documented as a risk in cancer patients undergoing certain breast cancer therapies, but widely accepted international guidelines do not exist for dealing with those complications.

Researchers debut practice of monitoring mitochondria to predict, prevent cardiac arrest

New technology developed by researchers at Boston Children’s Hospital in conjunction with Cambridge-based Pendar Technologies has the ability to monitor oxygen levels in human tissue and predict cardiac arrest in heart patients, a study published in Science Translational Medicine reports.

FDA approves pump to treat right heart failure

The FDA has granted pre-market approval to the Impella RP heart pump used in treating right heart failure, Abiomed announced Sept. 20.

Abbott's PA sensor system is clinically proven to work—but how safe is it?

Recent studies have proven Abbott’s wireless pulmonary artery (PA) sensor CardioMEMS HF System to be successful in reducing heart failure hospitalizations and dramatically lowering medical costs, but a study published in the Journal of the American Medical Association this month questions the safety of the device.

Scientists dissect the reasons behind sudden cardiac death in triathlons

Triathlons could be risky for athletes with heart disease, potentially leading to cardiac arrest or sudden death, according to a new Minneapolis Heart Institute Foundation study.

New heart failure treatment increases ejection fraction by 38% in 1st clinical patient

The first clinical patient to undergo a new, less invasive treatment for heart failure has been discharged from University Hospital Zurich in Switzerland and is recovering well, according to a press release from BioVentrix.

Sudden cardiac death a significant contributor to mortality in women, regardless of CAD status

Sudden cardiac death is a significant contributor to mortality in women, regardless of presence of coronary artery disease (CAD), according to a six-year study published in the Journal of the American Heart Association.

Researchers link aldosterone, plasma renin activity to increased risk for CVD in black Americans

Increased levels of aldosterone and plasma renin activity (PRA) are associated with greater risk of cardiovascular disease (CVD) and all-cause mortality among blacks in the U.S., according to a community-based study.

Hearts with improving LVSD can be safely transplanted

Donor hearts with left ventricular systolic dysfunction (LVSD) can be revived and transplanted as successfully as other hearts, according to a study in the Journal of the American College of Cardiology.

6 data points about rheumatic heart disease as global rates decline

Over the past quarter-century, the worldwide burden of rheumatic heart disease has declined although high rates of the illness persist in certain poor regions, including Oceania, South Asia and sub-Saharan Africa, a new study finds.